Can Fite (Israel) Price Prediction and Hype Density Breakdown

CANF -- Israel Stock  

ILS 246.00  0.10  0.0407%

We analyze noise-free headlines and recent hype associated with Can Fite BioPharma Ltd which may create opportunities for some arbitrage if properly timed. With Can Fite hype-based prediction module you can estimate the value of Can Fite BioPharma Ltd from the prospective of Can Fite response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Can Fite over a specific investment horizon. Check also Can Fite Basic Forecasting Models to cross-verify your projections.
Horizon     30 Days    Login   to change

Can Fite After-Hype Price Density Analysis

 Next price density 
      Expected price to next headline 

Can Fite Estimiated After-Hype Price Volatility

December 9, 2018
Current Value
After-hype Price
Target Odds
Can Fite is not too risky asset. Analysis and calculation of next after-hype price of Can Fite BioPharma is based on 2 months time horizon.

Can Fite Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.17% 2.92% 0.63%  1.05% 4 Events / Month4 Events / MonthIn about 4 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Can Fite Hype Timeline

Can Fite BioPharma Ltd is currently traded for 246.00on Tel Aviv Stock Exchange of Israel. This company has historical hype elasticity of -0.63 and average elasticity to hype of competition of 1.05. Can Fite BioPharma Ltd is anticipated to decline in value after the next headline with price expected to drop to 245.37. The average volatility of media hype impact on the company stock price is about 78.92%. The price decline on the next news is expected to be -0.26% where as daily expected return is currently at 0.17%. The volatility of related hype on Can Fite is about 47.25% with expected price after next announcement by competition of 247.05. The company recorded loss per share of 0.17. Can Fite BioPharma Ltd had not issued any dividends in recent years. This company had a split on 2013-05-12. Assuming 30 trading days horizon, the next anticipated press release will be in about 4 days.
Check also Can Fite Basic Forecasting Models to cross-verify your projections.

Can Fite Related Hype Analysis

At Risk
Kamada Ltd(3.00) 3 per month 0.00 (0.0074)  2.32 (2.47)  6.96 
RedHill Biopharma Ltd 0.00 7 per month 4.01  0.06  6.86 (6.55)  19.66 
BioTime 8.00 1 per month 0.00 (0.22)  5.65 (9.10)  16.21 
Compugen Ltd 3.00 7 per month 0.00  0.0126  3.52 (4.38)  15.94 
Clal Biotechnology Industries Ltd 4.20 3 per month 0.00  0.0112  2.92 (3.33)  9.16 
Pluristem Therapeutics 0.20 1 per month 0.00 (0.1)  2.42 (2.40)  8.49 
Evogene Ltd 54.30 6 per month 0.00 (0.09)  3.24 (3.08)  10.17 
Protalix BioTherapeutics(1.20) 2 per month 4.71  0.0386  14.13 (10.35)  29.36 
Can Fite BioPharma Ltd(3.70) 4 per month 1.94  0.14  4.04 (3.69)  14.85 
Solegreen Ltd 0.00 1 per month 1.31  0.14  3.32 (2.34)  7.75 

Latest Stories

Recently Published Macroaxis Stories

Investors are also interested in

Purchased over 50 shares
Active few hours ago
Purchased over 90 shares
Active few hours ago
Purchased over 70 shares
Active few hours ago
Purchased over 50 shares
Active few hours ago
Purchased over 500 shares
Active few hours ago
Purchased few shares
Active few hours ago
Check also Can Fite Basic Forecasting Models to cross-verify your projections. Please also try Price Ceiling Movement module to calculate and plot price ceiling movement for different equity instruments.